Metagenomic Study Reveals Phage-Bacterial Interactome Dynamics in Gut and Oral Microbiota in Pancreatic Diseases.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
12 Oct 2024
Historique:
received: 06 09 2024
revised: 04 10 2024
accepted: 10 10 2024
medline: 26 10 2024
pubmed: 26 10 2024
entrez: 26 10 2024
Statut: epublish

Résumé

Individuals with pancreatic-related health conditions usually show lower diversity and different composition of bacterial and viral species between the gut and oral microbiomes compared to healthy individuals. We performed a thorough microbiome analysis, using deep shotgun sequencing of stool and saliva samples obtained from patients with chronic pancreatitis (CP), pancreatic ductal adenocarcinoma (PDAC), and healthy controls (HCs).We observed similar microbiota composition at the species level in both the gut and oral samples in PDAC patients compared to HCs, among which the most distinctive finding was that the abundance of oral-originated

Identifiants

pubmed: 39456772
pii: ijms252010988
doi: 10.3390/ijms252010988
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundació la Marató de TV3
ID : 201912-31
Organisme : European Molecular Biology Organization
ID : 9986

Auteurs

Laura Vilà-Quintana (L)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Esther Fort (E)

Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

Laura Pardo (L)

Department of Gastroenterology, Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

Maria T Albiol-Quer (MT)

Hepato-Pancreato-Biliary Unit, Department of Surgery, Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

Maria Rosa Ortiz (MR)

Department of Pathology, Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

Montserrat Capdevila (M)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Anna Feliu (A)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Anna Bahí (A)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Marc Llirós (M)

Bioinformatics and Bioimaging (BI-SQUARED) Research Group, Biosciences Department, Faculty of Sciences, Technology and Engineering, Universitat de Vic, 08500 Vic, Spain.

Adelaida García-Velasco (A)

Precision Oncology Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.
Institut Català d'Oncologia (ICO), Hospital Universitari de Girona Dr. Josep Trueta, 17007 Girona, Spain.

Mireia Morell Ginestà (M)

Hereditary Cancer Program, Institut Català d'Oncologia (ICO), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIBERONC, 08908 Barcelona, Spain.

Berta Laquente (B)

Medical Oncology Department, Institut Català d'Oncologia (ICO), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.

Débora Pozas (D)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Victor Moreno (V)

Institut Català d'Oncologia (ICO), Institut de Recerca Biomedica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.
UBICS, University of Barcelona (UB), 08028 Barcelona, Spain.
Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), 08036 Barcelona, Spain.

Librado Jesús Garcia-Gil (LJ)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Eric Jeffrey Duell (EJ)

Cancer Epidemiology Research Program, Unit of Nutrition and Cancer, Institut Català d'Oncologia (ICO), Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), 08908 Barcelona, Spain.

Ville Nikolai Pimenoff (VN)

Department of Clinical Science, Intervention and Technology-CLINTEC, Karolinska Institutet, 14152 Stockholm, Sweden.
Unit of Population Health, Faculty of Medicine, University of Oulu, 90220 Oulu, Finland.

Robert Carreras-Torres (R)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Xavier Aldeguer (X)

Digestive Diseases and Microbiota Group, Girona Biomedical Research Institute (IDIBGI), 17190 Salt, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH